AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gazette M Tablet

Prescription Icon
Prescription Required

Marketer

Athens Labs Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Gazette M Tablet

DiaBetaDuo tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. DiaBetaDuo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use, even with controlled blood sugar or feeling well, is crucial. Discontinuing without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. DiaBetaDuo is only one component of a comprehensive diabetes management plan; a healthy diet, regular exercise, and weight management, as directed by your doctor, are equally vital. Lifestyle significantly impacts diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a fast-acting glucose source (e.g., sugary foods or juice) to counteract hypoglycemia. Regular meals are essential, and alcohol should be avoided due to its potential to lower blood sugar. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. DiaBetaDuo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Inform your doctor about any history of heart disease before starting treatment, as DiaBetaDuo may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood glucose monitoring, along with blood tests for cell counts and liver function, are recommended by your physician.

Primary Ingredients of Gazette M Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Gazette M Tablet

Adult-onset diabetes

Major Benefits of Gazette M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Gazette M Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consume Gazette M with a meal.

Common Side effects of Gazette M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gazette M Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gazette M Tablets should be administered with a meal.

How Gazette M Tablet works:

Gliclazide and metformin are combined in Gazette M Tablet, an antidiabetic medication.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Gazette M Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gazette M Tablet during pregnancy is unsafe due to established risks to the fetus. A physician might exceptionally prescribe it in life-threatening emergencies where benefits outweigh potential harm. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gazette M Tablet while breastfeeding is likely inadvisable. Available data from human studies indicate a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gazette M Tablet cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult your physician. Regular kidney function testing is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gazette M Tablet cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dosage; Gazette M Tablet is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gazette M Tablet :

Should you forget a Gazette M Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Gazette M Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Gazette M Tablet

Gliclazide and Metformin, the components of Gazette M Tablet, are used to manage type 2 diabetes mellitus in adults. This medication helps regulate blood sugar when combined with a healthy diet and exercise regimen. Gliclazide functions by stimulating insulin secretion from the pancreas, thereby reducing blood glucose. Metformin acts by decreasing hepatic glucose production and enhancing insulin responsiveness. This dual-drug formulation is unsuitable for treating type 1 diabetes.
Gazette M Tablet may cause several common side effects, such as low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious adverse reactions, including lactic acidosis, are also possible. Prolonged use might result in vitamin B12 deficiency.
Indeed, Gazette M Tablet can induce hypoglycemia, characterized by low blood glucose. Manifestations of this condition encompass nausea, headache, irritability, increased hunger, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with missed or delayed meals, alcohol consumption, excessive physical exertion, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Lactic acidosis, a serious medical condition stemming from excess blood lactate, is a potential adverse effect of Gazette M Tablet. This complication, also termed Metformin-associated lactic acidosis (MALA), though infrequent, necessitates caution. Patients with pre-existing kidney impairment, the elderly, and heavy alcohol consumers should avoid this medication. Warning signs may encompass muscular discomfort or weakness, vertigo, fatigue, peripheral coldness, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms arise, discontinue Gazette M Tablet use and seek immediate medical attention.
Indeed, prolonged Gazette M Tablet consumption can lead to vitamin B12 insufficiency. This deficiency arises from the medication's disruption of vitamin B12 absorption within the stomach. Left unaddressed, this can result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 is recommended by some experts at least annually.
Gazette M Tablets are contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient. Their use is also prohibited in patients exhibiting moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Gazette M Tablet with alcohol is unsafe. Concurrent use may dangerously reduce blood glucose, potentially causing hypoglycemia and raising the risk of lactic acidosis.
Gliclazide and Metformin, the components of Gazette M Tablet, are employed in managing type 2 diabetes mellitus. This medication helps regulate blood sugar in adults when used concurrently with a balanced diet and physical activity. Gliclazide functions by stimulating insulin secretion from the pancreas, thus reducing blood glucose. Metformin acts by decreasing hepatic glucose production and enhancing insulin responsiveness. This combination therapy is unsuitable for type 1 diabetes.
Gazette M Tablet administration is linked to several common adverse reactions. These may manifest as hypoglycemia, altered taste perception, nausea, abdominal discomfort, diarrhea, cephalalgia, and upper respiratory infections. Rare, but potentially severe, side effects such as lactic acidosis have also been reported. Prolonged use may result in vitamin B12 deficiency.
Indeed, Gazette M Tablet may induce hypoglycemia, characterized by low blood glucose. Manifestations of this condition can encompass nausea, headache, irritability, hunger pangs, diaphoresis, vertigo, tachycardia, and feelings of apprehension or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily accessible glucose tablets, honey, or fruit juice is advisable.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential side effect of Gazette M Tablet. Also termed Metformin-associated lactic acidosis (MALA), this rare complication is preventable by avoiding use in individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms appear, discontinue Gazette M Tablet and seek immediate medical attention.
Indeed, prolonged Gazette M Tablet consumption can lead to vitamin B12 insufficiency. This deficiency arises because the medication hinders the stomach's absorption of vitamin B12. Left unaddressed, this can result in anemia, neurological complications, including paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive impairment, and gait instability. To mitigate these risks, some studies recommend supplemental vitamin B12 intake annually.
Gazette M Tablets are contraindicated in individuals with hypersensitivity to any constituent or inactive ingredient. The medication should also not be administered to patients exhibiting moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Gazette M Tablet with alcohol is unsafe. Concurrent use may reduce blood sugar to dangerously low levels (hypoglycemia) and heighten the risk of lactic acidosis.
Gazette M Tablet
39
MRP 48
18% off